We assign a fundamental rating of 5 out of 10 to IOSP. IOSP was compared to 82 industry peers in the Chemicals industry. IOSP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IOSP has a valuation in line with the averages, but it does not seem to be growing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.07% | ||
| ROE | -0.09% | ||
| ROIC | 9.58% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.31% | ||
| PM (TTM) | N/A | ||
| GM | 28.01% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.78 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.78 | ||
| Quick Ratio | 1.81 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.11 | ||
| Fwd PE | 13.19 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 67.54 | ||
| EV/EBITDA | 7.51 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.35% |
74.95
-0.09 (-0.12%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.35% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.11 | ||
| Fwd PE | 13.19 | ||
| P/S | 1.04 | ||
| P/FCF | 67.54 | ||
| P/OCF | 18.1 | ||
| P/B | 1.43 | ||
| P/tB | 2.23 | ||
| EV/EBITDA | 7.51 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.07% | ||
| ROE | -0.09% | ||
| ROCE | 11.54% | ||
| ROIC | 9.58% | ||
| ROICexc | 11.8% | ||
| ROICexgc | 19.5% | ||
| OM | 9.31% | ||
| PM (TTM) | N/A | ||
| GM | 28.01% | ||
| FCFM | 1.54% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 166.52% | ||
| Cap/Sales | 4.2% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 48.49% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.78 | ||
| Quick Ratio | 1.81 | ||
| Altman-Z | 4.78 |
ChartMill assigns a fundamental rating of 5 / 10 to IOSP.
ChartMill assigns a valuation rating of 4 / 10 to INNOSPEC INC (IOSP). This can be considered as Fairly Valued.
INNOSPEC INC (IOSP) has a profitability rating of 5 / 10.
The financial health rating of INNOSPEC INC (IOSP) is 8 / 10.
The Earnings per Share (EPS) of INNOSPEC INC (IOSP) is expected to decline by -14.21% in the next year.